- Home
- CLRB vs RMCO Comparison
CLRB vs RMCO Comparison
Compare CLRB & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- RMCO
- Stock Information
- Founded
- CLRB 2002
- RMCO 2021
- Country
- CLRB United States
- RMCO United States
- Employees
- CLRB N/A
- RMCO N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- RMCO Multi-Sector Companies
- Sector
- CLRB Health Care
- RMCO Miscellaneous
- Exchange
- CLRB Nasdaq
- RMCO Nasdaq
- Market Cap
- CLRB 17.6M
- RMCO 14.9M
- IPO Year
- CLRB N/A
- RMCO N/A
- Fundamental
- Price
- CLRB $4.98
- RMCO $1.30
- Analyst Decision
- CLRB Hold
- RMCO
- Analyst Count
- CLRB 2
- RMCO 0
- Target Price
- CLRB N/A
- RMCO N/A
- AVG Volume (30 Days)
- CLRB 1.3M
- RMCO 18.7K
- Earning Date
- CLRB 08-12-2025
- RMCO 08-14-2025
- Dividend Yield
- CLRB N/A
- RMCO 0.19%
- EPS Growth
- CLRB N/A
- RMCO N/A
- EPS
- CLRB N/A
- RMCO N/A
- Revenue
- CLRB N/A
- RMCO $1,568,212.00
- Revenue This Year
- CLRB N/A
- RMCO N/A
- Revenue Next Year
- CLRB N/A
- RMCO N/A
- P/E Ratio
- CLRB N/A
- RMCO N/A
- Revenue Growth
- CLRB N/A
- RMCO 204.08
- 52 Week Low
- CLRB $4.36
- RMCO $0.74
- 52 Week High
- CLRB $94.50
- RMCO $1.41
- Technical
- Relative Strength Index (RSI)
- CLRB 33.34
- RMCO 66.86
- Support Level
- CLRB $6.50
- RMCO $1.19
- Resistance Level
- CLRB $8.30
- RMCO $1.30
- Average True Range (ATR)
- CLRB 1.42
- RMCO 0.07
- MACD
- CLRB -0.66
- RMCO 0.02
- Stochastic Oscillator
- CLRB 1.63
- RMCO 67.65
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.